Know Cancer

or
forgot password

    • cancer clinical trials in mesquite, TX

    • PhII ICb With/Without Erbitux in MBC Pts
    Texas Cancer Center of Mesquite
    Mesquite, Texas 75150
    Metastatic Breast Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Texas Cancer Center of Mesquite
    Mesquite, Texas 75150
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Texas Cancer Center of Mesquite
    Mesquite, Texas 75150
    Breast Cancer
    Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
    Texas Cancer Center of Mesquite
    Mesquite, Texas 75150
    Metastatic Gastric or GEJ Cancer
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    Texas Cancer Center of Mesquite
    Mesquite, Texas 75150
    Androgen-independent Prostate Cancer
    Sunitinib Non Small Cell Lung Cancer Patients Over 70
    Texas Cancer Center of Mesquite
    Mesquite, Texas 75150
    Non Small Cell Lung Cancer
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Texas Oncology-Mesquite
    Mesquite, Texas 75150
    Metastatic Breast Cancer
    Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    US Oncology - Texas Oncology - Mesquite
    Mesquite, Texas 75150
    Chronic Lymphocytic Leukemia
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Texas Oncology-Mesquite
    Mesquite, Texas 75150
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
    Texas Cancer Center of Mesquite
    Mesquite, Texas 75150
    Prostate Cancer, Hormone Refractory Prostate Cancer
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Texas Cancer Center of Mesquite
    Mesquite, Texas 75150
    Non-Small Cell Lung Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Texas Cancer Center of Mesquite
    Mesquite, Texas 75150
    Carcinoma, Non-Small-Cell Lung
    Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer
    Texas Cancer Center of Mesquite
    Mesquite, Texas 75150
    Colorectal Cancer Metastatic
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Texas Cancer Center of Mesquite
    Mesquite, Texas 75150
    Metastatic Breast Cancer
    Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer
    Texas Cancer Center of Mesquite
    Mesquite, Texas 75150
    Metastatic Breast Cancer